Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients

Atherosclerosis ◽

10.1016/j.atherosclerosis.2014.05.942 ◽

2014 ◽

Vol 235 (2) ◽

pp. 415-417 ◽

Author(s):

Gian Paolo Fadini ◽

Elisabetta Iori ◽

Maria Cristina Marescotti ◽

Saula Vigili de Kreutzenberg ◽

Angelo Avogaro

Keyword(s):

Glucose Control ◽

Reverse Cholesterol Transport ◽

Hdl Cholesterol ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Cholesterol Levels ◽

Type 2 Diabetic

Download Full-text

Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

Diabetic Medicine ◽

10.1046/j.1464-5491.2001.00507.x ◽

2001 ◽

Vol 18 (6) ◽

pp. 509-513 ◽

Author(s):

R. P. F. Dullaart ◽

A. Van Tol

Keyword(s):

Reverse Cholesterol Transport ◽

Healthy Subjects ◽

Cholesterol Efflux ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Cellular Cholesterol Efflux ◽

Type 2 Diabetic

Download Full-text

262 High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease

Archives of Cardiovascular Diseases Supplements ◽

10.1016/s1878-6480(11)70264-6 ◽

2011 ◽

Vol 3 (1) ◽

pp. 86

Author(s):

Nebil Attia ◽

Amel Nakbi ◽

Khaldoun Ben Hamda ◽

Sonia Hammami ◽

Raja Châaba ◽

...

Keyword(s):

Coronary Artery Disease ◽

Reverse Cholesterol Transport ◽

Density Lipoprotein ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Factor Effect ◽

Artery Disease ◽

Type 2 Diabetic

Download Full-text

HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.e512 ◽

2008 ◽

Vol 15 (1) ◽

pp. 20-25 ◽

Author(s):

Jing-Zhi Guan ◽

Naoki Tamasawa ◽

Hiroshi Murakami ◽

Jun Matsui ◽

Jutaro Tanabe ◽

...

Keyword(s):

Reverse Cholesterol Transport ◽

Reductase Inhibitor ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase ◽

Type 2 Diabetic

Download Full-text

High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2010.06.010 ◽

2010 ◽

Vol 43 (13-14) ◽

pp. 1079-1084 ◽

Author(s):

Nebil Attia ◽

Anne-Marie Lorec ◽

Nicole Domingo ◽

Amel Nakbi ◽

Sonia Hammami ◽

...

Keyword(s):

Coronary Artery Disease ◽

Reverse Cholesterol Transport ◽

Density Lipoprotein ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Factor Effect ◽

Artery Disease ◽

Type 2 Diabetic

Download Full-text

Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment

Atherosclerosis ◽

10.1016/s0021-9150(00)00428-7 ◽

2000 ◽

Vol 153 (2) ◽

pp. 453-460 ◽

Author(s):

Delphine Autran ◽

Nebil Attia ◽

Marek Dedecjus ◽

Vincent Durlach ◽

Anik Girard-Globa

Keyword(s):

Reverse Cholesterol Transport ◽

Lipid Lowering ◽

Diabetic Patients ◽

Cholesterol Transport ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text

LDL cholesterol/HDL cholesterol ratio in newly diagnosed type 2 diabetic patients complicated with metabolic syndrome

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.01396 ◽

2014 ◽

Vol 35 (12) ◽

pp. 1396

Author(s):

Jue JIA ◽

Shu-qin YU ◽

Jing-jing YE ◽

Jiang-ning YIN ◽

Dong WANG ◽

...

Keyword(s):

Metabolic Syndrome ◽

Ldl Cholesterol ◽

Hdl Cholesterol ◽

Diabetic Patients ◽

Newly Diagnosed ◽

Type 2 Diabetic Patients ◽

Cholesterol Ratio ◽

Type 2 Diabetic

Download Full-text

Glucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2021.108080 ◽

2021 ◽

pp. 108080

Author(s):

Tatsumi Moriya ◽

Akinori Hayashi ◽

Madoka Matsubara ◽

Akihiko Suzuki ◽

Motoshi Ouchi

Keyword(s):

Renal Function ◽

Diabetic Retinopathy ◽

Normal Renal Function ◽

Glucose Control ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text

Effect of combined training versus aerobic training alone on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis

International Journal of Diabetes in Developing Countries ◽

10.1007/s13410-015-0329-9 ◽

2015 ◽

Vol 35 (4) ◽

pp. 524-532 ◽

Author(s):

Yunying Hou ◽

Lu Lin ◽

Wei Li ◽

Jingbo Qiu ◽

Yonghong Zhang ◽

...

Keyword(s):

Risk Factors ◽

Glucose Control ◽

Aerobic Training ◽

Meta Analysis ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Combined Training ◽

Type 2 Diabetic

Download Full-text

Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring

Diabetes & Metabolism ◽

10.1016/j.diabet.2010.03.002 ◽

2010 ◽

Vol 36 (3) ◽

pp. 240-243 ◽

Author(s):

V. Thielen ◽

A. Scheen ◽

J. Bringer ◽

E. Renard

Keyword(s):

Real Time ◽

Glucose Control ◽

Glucose Monitoring ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text

Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets

Journal of Diabetes ◽

10.1111/1753-0407.12373 ◽

2016 ◽

Vol 9 (1) ◽

pp. 34-44 ◽

Author(s):

Manel Mata-Cases ◽

Dídac Mauricio ◽

Josep Franch-Nadal

Keyword(s):

Insulin Therapy ◽

Glucose Control ◽

Basal Insulin ◽

Clinical Characteristics ◽

Fasting Glucose ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text